Methods : A total of 178 patients with AIS due to LVO were assigned to undergo MT alone ( MT-alone group ) or MT preceded by intravenous alteplase ( the combined group ) , at a dose of 0.9 mg per kilogram , administered within 4.5 hours after symptom onset ( combined group ) .